Subtitle: Market Intelligence, Clinical Progress, and High-Purity Reagents for Migraine, Sepsis, and Diagnostic Development.
TarMart Solution Ecosystem & Related Targets
Comprehensive reagent toolkit for CALCA/CGRP/Procalcitonin drug discovery. Select your modality below:
| Component / Network | Product Description | Product Link |
|---|---|---|
| Antigen | CALCA/CGRP/Procalcitonin Recombinant Protein (CGRP-alpha, Calcitonin, Procalcitonin). High purity (>95%), Endotoxin <1 EU/µg. Sequence Verified, theoretical MW confirmed. | View CALCA Products |
| Gene Delivery | CALCA Promise-ORF / Lentivirus. Full-length ORF for stable cell lines and secretion models. | View CALCA Products |
| Benchmark Ab | Anti-CGRP (Sequence of Galcanezumab / Fremanezumab). Recombinant positive control for binding and competition assays. | View CALCA Products |
| Validator | CALCA siRNA Set. For knockdown verification in expression and secretion studies. | View CALCA Products |
| Related Target A | RAMP1. Core component of the CGRP receptor complex for migraine screening. | View RAMP1 Products |
| Related Target B | CALCRL (CRLR). Calcitonin receptor-like receptor, pairs with RAMP1 for cell-based functional assays. | View CALCRL Products |
| Related Target C | CALCB (CGRP-beta). Closely related neuropeptide; essential for cross-reactivity and pan-CGRP assay panels. | View CALCB Products |
| Critical Assay Challenge | The TarMart Advantage (Technical Spec) |
|---|---|
| Receptor Complex Formation (RAMP1/CALCRL) | HEK293 Expressed (Native Glycosylation) subunits for accurate conformation |
| Peptide Stability in Assays | High Purity (>95%) synthetic and recombinant CGRP peptides |
| Lack of Controls | Clinical Benchmark Antibodies (Biosimilars) included |
| False Positives in Diagnostic Development (PCT) | Strictly sequence-verified Procalcitonin variants for ELISA baseline testing |
| Cross-species Cyno / Mouse evaluation | Human / Mouse / Cynomolgus ortholog proteins available with >95% purity and endotoxin <1 EU/µg |
| CGRP isoform & family counter-screening (α vs β vs Calcitonin) | Strictly sequence-verified isoform panel (CGRP-alpha, CGRP-beta, Calcitonin) by mass spec |
| Diagnostic PCT calibrator standardization | Full-length Procalcitonin, HEK293 expressed, high batch-to-batch consistency, theoretical MW confirmed |
Live CALCA/CGRP/Procalcitonin R&D Tracker
Market data changes daily. Access the latest global pipeline status directly:
- ➤ View Active Clinical Trials (CGRP & PCT)
- ➤ Latest Resistance Research
- ➤ Recent Patent Filings
- ➤ CGRP Migraine Clinical Trials
- ➤ CGRP Antagonist Patents
Global Clinical Landscape & Future Outlook
The race for CALCA/CGRP-directed therapeutics has matured into a multi-billion-dollar market, with major players dominating the migraine space through anti-CGRP mAbs (Erenumab, Fremanezumab, Galcanezumab) and small molecule gepants (Ubrogepant, Rimegepant). As first-generation therapies establish a massive market presence, the next wave of R&D is targeting optimized oral delivery, sub-Q formulations with extended half-lives, and improved hepatobiliary safety profiles. Simultaneously, Procalcitonin (PCT) has emerged as a critical biomarker for sepsis severity and antibiotic stewardship, driving demand for high-sensitivity diagnostic reagents at the point of care.
Competitive Modality & Indication Snapshot
| Modality | Representative Players | Key Indications | Critical Assay Need (Why TarMart?) |
|---|---|---|---|
| Anti-CGRP Monoclonal Antibody | Lilly, Teva, Amgen, Lundbeck | Migraine Prevention | Ligand binding assay (Need high-purity CGRP-alpha and CGRP-beta) |
| Small Molecule (Gepants) | AbbVie, Pfizer / Biohaven | Acute & Preventive Migraine | Receptor binding assay (Need cell lines / Lentivirus; selectivity over Calcitonin/Amylin) |
| Anti-CGRP Receptor mAb | Amgen / Novartis | Migraine Prevention | CGRP-CLR/RAMP1 competition (Need recombinant CGRP ligand standards) |
| Diagnostic Reagent (PCT IVD) | Roche, Abbott, Thermo Fisher / B·R·A·H·M·S, bioMérieux | Sepsis, Bacterial Infection | Calibrator / Standard (Need full-length Procalcitonin antigen, endotoxin controlled) |
Key Genetic Variants in CALCA
CALCA gene encodes the calcitonin/CGRP/procalcitonin preproprotein. Key single nucleotide polymorphisms (SNPs) with documented evidence in UniProt (P01258) include:
- rs34587547 (VAR_025271)
- rs5239 (VAR_014592)
- rs34164367 (VAR_025272) These variants may influence peptide processing, expression levels, or disease association in migraine and sepsis populations. Researchers requiring sequence-verified mutant proteins for functional studies should inquire about custom mutant panels.
TarMart Advantage Summary
TarMart provides a comprehensive, high-purity reagent ecosystem for CALCA/CGRP/Procalcitonin R&D: strict sequence verification, endotoxin control (<1 EU/µg), HEK293-expressed native glycosylation for receptor subunits, and clinical benchmark antibodies. Our reagents enable accurate assay development for both therapeutic and diagnostic applications, supported by validated siRNA controls and cross-species orthologs.